Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

274 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SARS-CoV-2 N protein and anti-spike serologies: insights into COVID-19 disease severity and mortality-a secondary analysis of the ACTIV-1 trial.
Mena Lora AJ, Enders K, Wu H, Parra-Rodriguez L, Palma C, Saliba K, Laverdurre S, Smith PB, Anstrom KJ, Bozzette SA, Powderly WG. Mena Lora AJ, et al. Among authors: powderly wg. Ther Adv Infect Dis. 2025 Apr 22;12:20499361251333617. doi: 10.1177/20499361251333617. eCollection 2025 Jan-Dec. Ther Adv Infect Dis. 2025. PMID: 40297751 Free PMC article.
Distinct Inflammatory Phenotypes Are Associated With Subclinical and Clinical Cardiovascular Disease in People With Human Immunodeficiency Virus.
McGettrick P, Tinago W, O'Brien J, Miles S, Lawler L, Garcia-Leon A, Mahon N, Lambert J, Sheehan G, Landay A, Sabin CA, Cotter AG, Mallon PWG; HIV Understanding the Pathology of Comorbid Disease in HIV-Infected Individuals With Coronary Artery Disease (UPBEAT) Study Group and the All Ireland Infectious Diseases (AIID) Cohort Study. McGettrick P, et al. J Infect Dis. 2024 Sep 23;230(3):e616-e621. doi: 10.1093/infdis/jiae007. J Infect Dis. 2024. PMID: 38214571 Free PMC article.
Associations Between the Gut Microbiome, Inflammation, and Cardiovascular Profiles in People With Human Immunodeficiency Virus.
MacCann R, Li J, Leon AAG, Negi R, Alalwan D, Tinago W, McGettrick P, Cotter AG, Landay A, Sabin C, O'Toole PW, Mallon PWG; Understanding the Pathology of Comorbid Disease in HIV-Infected Individuals (HIV UPBEAT) Study Group. MacCann R, et al. J Infect Dis. 2025 Apr 15;231(4):e781-e791. doi: 10.1093/infdis/jiaf043. J Infect Dis. 2025. PMID: 39854172 Free PMC article.
Long-term exposure to lifelong therapies.
Powderly WG. Powderly WG. J Acquir Immune Defic Syndr. 2002 Feb 1;29 Suppl 1:S28-40. doi: 10.1097/00126334-200202011-00005. J Acquir Immune Defic Syndr. 2002. PMID: 11832699 Review.
Infliximab Pharmacokinetics, Dosing, and Response in Hospitalized Patients with COVID-19 Pneumonia: A Secondary Analysis of a Multinational Randomized Clinical Trial (ACTIV-1 IM).
Balevic SJ, Gonzalez D, Smith PB, Powderly WG, Schmid A, Kang A, McCarthy MW, Shaw LK, Lindsell CJ, Bozzette S, Hoetelmans RMW, Hornik CP, Benjamin DK Jr; ACTIV‐1 IM Study Group Members. Balevic SJ, et al. Among authors: powderly wg. J Clin Pharmacol. 2025 Nov;65(11):1497-1505. doi: 10.1002/jcph.70057. Epub 2025 Jun 9. J Clin Pharmacol. 2025. PMID: 40488513 Clinical Trial.
Resource Use in the Randomized Master Protocol for Immune Modulators for Treating COVID-19 (ACTIV-1 IM): A Secondary Data Analysis.
Lachiewicz AM, Shah M, Der T, Cyr D, Al-Khalidi HR, Lindsell C, Iyer V, Khan A, Panettieri R, Rauseo AM, Maillo M, Schmid A, Jagpal S, Powderly WG, Bozzette SA; ACTIV-1 IM study group members. Lachiewicz AM, et al. Among authors: powderly wg. CHEST Crit Care. 2024 Dec;2(4):100095. doi: 10.1016/j.chstcc.2024.100095. Epub 2024 Aug 22. CHEST Crit Care. 2024. PMID: 39610848 Free PMC article.
274 results